Toggle navigation
Home
Search
Services
Blog
Contact
About
Pediatric Hydroxyurea Phase III Clinical Trial
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Association of genetic and autoantibody signatures with SLE clinical course
Hormonal Regulation of Breast Cancer
Neuro-immunophyllin Ligand Mechanism of Action in Reducing Alcohol Preference
Minority Predoctoral Fellowship Program
Synthesis of Molybdopterin and the Molybdenum Cofactor
Recently added grants:
Targeting Oncogenic Ras-MAPK Signaling Complexes via the Scaffold KSR
Radiotherapy-associated breast cancer: machine learning on genotypes to predict individualized risk
Systematic identification of astrocyte-tumor crosstalk regulating brain metastatic tumors
Metabolic Control of Innate and Adaptive Immunity in Breast Cancer
Investigating YAP1 control of differentiation and metabolism in Hepatoblastoma
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research and Development Contracts (N01)
Project #
N01HB07151-17-0-1
Application #
7574820
Study Section
Project Start
2000-09-01
Project End
2009-03-31
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 HL
Pediatric Hydroxyurea Phase III Clinical Trial
/ Duke University
$270,293
NIH 2007
N01 HL
Pediatric Hydroxyurea Phase III Clinical Trial
Thornburg, Courtney /
$292,009
NIH 2007
N01 HL
Pediatric Hydroxyurea Phase III Clinical Trial
/
NIH 2007
N01 HL
/
Comments
Be the first to comment on this grant